Will MIR report Q1 2026 organic revenue growth at or above guided levels?
Current Prediction
Prediction Distribution
Individual Predictions(9 runs)
Conservative guides met ~70% of time. 90%+ nuclear plant presence provides stable base.
Flat N&S guide achievable from installed base. Medical mid-single-digit supported by Q4 trends.
Conservative guides with Q1 order book visibility. Nuclear services contracts provide predictable revenue.
Conservative guides met ~70% of time. 90%+ nuclear plant presence provides stable base.
Flat N&S guide achievable from installed base. Medical mid-single-digit supported by Q4 trends.
Conservative guides with Q1 order book visibility. Nuclear services contracts provide predictable revenue.
Conservative guides met ~70% of time. 90%+ nuclear plant presence provides stable base.
Flat N&S guide achievable from installed base. Medical mid-single-digit supported by Q4 trends.
Conservative guides with Q1 order book visibility. Nuclear services contracts provide predictable revenue.
Resolution Criteria
Resolves YES if MIR reports Q1 2026 organic growth at or above guided levels (flat N&S, mid-single-digit Medical). Resolves NO if either segment misses.
Resolution Source
Mirion Q1 2026 earnings release
Source Trigger
Q1 2026 organic growth: Management guided flat N&S organic, mid-single-digit medical.
Full multi-lens equity analysis